Variant chr14-22843714-T-C details in Genebe, Genetics Data Aggregator

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004995.4(MMP14):c.855T>C(p.Gly285=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.215 in 1,585,932 control chromosomes in the GnomAD database, including 38,274 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4628 hom., cov: 31)

Exomes 𝑓: 0.21 ( 33646 hom. )

Consequence

MMP14
NM_004995.4 synonymous

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.841

Variant links:

Genes affected

MMP14 (HGNC:7160): (matrix metallopeptidase 14) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily; each member of this subfamily contains a potential transmembrane domain suggesting that these proteins are expressed at the cell surface rather than secreted. This protein activates MMP2 protein, and this activity may be involved in tumor invasion. [provided by RefSeq, Jul 2008]

MMP14 links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.8).

BP6

Variant 14-22843714-T-C is Benign according to our data. Variant chr14-22843714-T-C is described in ClinVar as [Benign]. Clinvar id is 1177852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=0.841 with no splicing effect.

BA1

GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.362 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
MMP14	NM_004995.4 linkuse as main transcript	c.855T>C	p.Gly285=	synonymous_variant	6/10	ENST00000311852.11

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris
MMP14	ENST00000311852.11 linkuse as main transcript	c.855T>C	p.Gly285=	synonymous_variant	6/10	1	NM_004995.4	P1
MMP14	ENST00000548162.2 linkuse as main transcript	c.855T>C	p.Gly285=	synonymous_variant	6/10	5
MMP14	ENST00000680097.1 linkuse as main transcript	c.*170T>C		3_prime_UTR_variant, NMD_transcript_variant	6/10
MMP14	ENST00000680941.1 linkuse as main transcript	c.*253T>C		3_prime_UTR_variant, NMD_transcript_variant	7/11

Frequencies

GnomAD3 genomes

AF:

0.238

AC:

35999

AN:

151342

Hom.:

4609

Cov.:

show subpopulations

Gnomad AFR

AF:

0.310

Gnomad AMI

AF:

0.238

Gnomad AMR

AF:

0.204

Gnomad ASJ

AF:

0.195

Gnomad EAS

AF:

0.376

Gnomad SAS

AF:

0.230

Gnomad FIN

AF:

0.161

Gnomad MID

AF:

0.237

Gnomad NFE

AF:

0.206

Gnomad OTH

AF:

0.252

GnomAD3 exomes

AF:

0.217

AC:

48562

AN:

224188

Hom.:

5778

AF XY:

0.216

AC XY:

26329

AN XY:

121966

show subpopulations

Gnomad AFR exome

AF:

0.312

Gnomad AMR exome

AF:

0.125

Gnomad ASJ exome

AF:

0.193

Gnomad EAS exome

AF:

0.375

Gnomad SAS exome

AF:

0.227

Gnomad FIN exome

AF:

0.163

Gnomad NFE exome

AF:

0.210

Gnomad OTH exome

AF:

0.209

GnomAD4 exome

AF:

0.212

AC:

304378

AN:

1434474

Hom.:

33646

Cov.:

AF XY:

0.212

AC XY:

151448

AN XY:

713424

show subpopulations

Gnomad4 AFR exome

AF:

0.316

Gnomad4 AMR exome

AF:

0.137

Gnomad4 ASJ exome

AF:

0.197

Gnomad4 EAS exome

AF:

0.385

Gnomad4 SAS exome

AF:

0.224

Gnomad4 FIN exome

AF:

0.163

Gnomad4 NFE exome

AF:

0.206

Gnomad4 OTH exome

AF:

0.223

GnomAD4 genome

AF:

0.238

AC:

36058

AN:

151458

Hom.:

4628

Cov.:

AF XY:

0.236

AC XY:

17496

AN XY:

74010

show subpopulations

Gnomad4 AFR

AF:

0.310

Gnomad4 AMR

AF:

0.203

Gnomad4 ASJ

AF:

0.195

Gnomad4 EAS

AF:

0.376

Gnomad4 SAS

AF:

0.231

Gnomad4 FIN

AF:

0.161

Gnomad4 NFE

AF:

0.206

Gnomad4 OTH

AF:

0.257

Alfa

AF:

0.211

Hom.:

2660

Bravo

AF:

0.245

Asia WGS

AF:

0.331

AC:

1150

AN:

3478

ClinVar

Significance: Benign

Submissions summary: Benign:4

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Benign:3

Benign, criteria provided, single submitter	clinical testing	GeneDx	May 04, 2021	- -
Benign, criteria provided, single submitter	not provided	Breakthrough Genomics, Breakthrough Genomics	-	- -
Benign, criteria provided, single submitter	clinical testing	Labcorp Genetics (formerly Invitae), Labcorp	Jan 31, 2024	- -

MMP14-related disorder

Benign:1

Benign, no assertion criteria provided

clinical testing

PreventionGenetics, part of Exact Sciences

Nov 12, 2019

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.80

CADD

Benign

9.3

DANN

Benign

0.60

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over